Profil
Amir Tavakkol currently works at Timber Pharmaceuticals LLC, as Chief Scientific Officer from 2019.
Dr. Tavakkol also formerly worked at Merck & Co., Inc., as Executive Director-Project Leadership, Schering-Plough Corp., as Senior Director, Novartis Pharmaceuticals Corp., as Clinical Director-Lamisil & Famvir, Colgate-Palmolive Co., as Principal, Viamet Pharmaceuticals, Inc., as Chief Development Officer from 2014 to 2017, the University of Michigan, as Professor-Dermatology Department, Topica Pharmaceuticals, Inc., as Senior VP-Clinical Development & Operations from 2011 to 2014, Castle Creek Biosciences, Inc., as Chief Development Officer from 2017 to 2018, and Timber Pharmaceuticals, Inc., as Chief Scientific Officer from 2020 to 2021.
Dr. Tavakkol received his doctorate degree in 1984 from The University of Manchester.
Postes actifs de Amir Tavakkol
| Sociétés | Poste | Début |
|---|---|---|
Timber Pharmaceuticals LLC
Timber Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Directeur Technique/Scientifique/R&D | 01/03/2019 |
Anciens postes connus de Amir Tavakkol
| Sociétés | Poste | Fin |
|---|---|---|
| TREX WIND-DOWN, INC. | Directeur Technique/Scientifique/R&D | 04/02/2021 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Corporate Officer/Principal | 01/09/2018 |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Corporate Officer/Principal | 01/10/2017 |
Topica Pharmaceuticals, Inc.
Topica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops treatment for onychomycosis, or fungal infections of the nail and nail bed | Directeur des opérations | 01/07/2014 |
| COLGATE-PALMOLIVE COMPANY | Corporate Officer/Principal | - |
Formation de Amir Tavakkol
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Colgate-Palmolive Co.
Colgate-Palmolive Co. Household/Personal CareConsumer Non-Durables Manufactures and sells oral, personal, home care & pet nutritional products | Consumer Non-Durables |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Topica Pharmaceuticals, Inc.
Topica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops treatment for onychomycosis, or fungal infections of the nail and nail bed | Health Technology |
Timber Pharmaceuticals LLC
Timber Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes therapies for treatment of orphan dermatologic diseases | Health Technology |
















